TRIAL Holdings, Inc.
141AGrocery & Drug Retail
¥4,070.00+6.82%As of Oct 29vs prior close
- Market cap
- $3.2B
- P/E (TTM)
- 142.6×
- P/E (FY1)
- 44.4×
- From 52W high
- −14.36%
- EPS (LTM)
- ¥28.55
- Revenue (LTM)
- ¥1.4T
- Net margin
- 0.26%
- Dividend yield
- 0.42%
Nomior Score
52
Steady ProfileTop 47% of the scored universe
Growth60
Quality42
Value44
Momentum78
Resilience35
Growth
+10.52%revenue a year over 3 fiscal years
YE22 ¥595.5BLTM ¥1.4T
Connections
Revenue to profitYE25
1% of revenue became net profit.